Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen in SGA Children
NCT01067352Phase 3Terminated
- Sponsor
- Merck KGaA
- Start
- Feb 2004
- Primary completion
- Jul 2009
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Small for gestational age (SGA), sponsored by Merck KGaA. Started Feb 2004; status: terminated.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT01067352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067352.